The success of Sildenafil initially drove a boom for pharma, but recent developments present a complicated scenario for those considering a stake. Generic versions are reducing profits, and continued patent challenges https://nicoleymzm247901.bloguerosa.com/39857204/viagra-and-big-pharma-a-risky-bet